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Abstract 
 
In order to prevent duplication or loss of genomic regions during DNA replication it is 
essential that the entire genome is copied precisely once every S phase. Cells achieve 
this by mutually exclusive regulation of origin firing and licensing. A crucial protein 
involved in origin licensing is Cdt1, and therefore activity of this protein must be 
strictly controlled. Four recent papers demonstrate that PCNA, an essential sliding 
clamp used in replication and DNA repair, plays a crucial role in this process by 
mediating the proteasomal degradation of Cdt1. 
 
Regulation of replication origin firing 
 
Control of DNA replication is vital to maintenance of genome stability as too little 
replication during S phase would result in loss of genetic information whereas too 
much would result in duplication of some loci. Thus, cells have robust mechanisms to 
ensure DNA is replicated exactly once per cell cycle. Crucial for this is the process of 
origin licensing. During G1 phase of the cell cycle, before DNA synthesis begins, 
each origin is licensed by the formation of a pre-RC. When a cell enters S phase the 
licensed origins fire, recruiting the replication machinery, and the ability to form such 
pre-RCs is turned off. Hence only origins that were pre-licensed, and not those that 
have just been replicated, can become active. Once all replication has finished, cells 
inactivate their replication initiation activity and re-activate the licensing machinery, 
ensuring an oscillation between licensing and replicating states [1].  
 
This oscillation is under the overall control of the various CDKs that regulate the cell 
cycle. In G1 phase, when CDK activity is low, licensing proteins such as Cdc6 and 
Cdt1 are active and initiation proteins such as Cdc7/Dbf4 are inactive. In S phase and 
G2 when CDK activity is high the opposite scenario is enacted (Figure 1). This 
temporal regulation of activity/inactivity is brought about by a number of cellular 
events controlled directly or indirectly by the CDKs. These vary between species but 
include protein activation or inactivation by phosphorylation, sequestration of 
nuclear-acting proteins in the cytoplasm, protein inhibition (by the binding of 
inhibitory partners) and specific protein degradation (Figure 2)[2].  
 
The licensing protein Cdt1 
 
Cdt1 is essential for licensing in yeasts and higher eukaryotes. Cellular control of 
Cdt1 activity is complex, involving association with a regulatory partner (geminin) in 
metazoans and nuclear exclusion in yeast [3]. Furthermore, Cdt1 is also degraded by 
the proteasome both in S and G2 phases as well as after DNA damage induced by UV 
and gamma irradiation, and this degradation requires signals in the N-terminus of the 
protein. Both the SCF-Skp2 and the Cul4-DDB1 E3 ubiquitin ligases have been 
implicated in this degradation [4-7]. Recent studies provide evidence that PCNA is a 
crucial component of this destruction pathway [8-11]. 
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The replication protein PCNA 
 
PCNA has roles in many fundamental cellular processes. This homotrimeric ring 
encircles duplex DNA and slides along it, tethering PCNA-interacting proteins to 
DNA. The most crucial role of PCNA is during replication where it is an essential co-
factor for DNA polymerases. After origin firing, when the two parental DNA strands 
have been separated by the replicative helicase, PCNA is loaded onto both leading 
and lagging strands. Many of the key steps in replication, including DNA 
polymerisation, Okazaki fragment processing and ligation, DNA methylation, 
mismatch repair and chromatin assembly are mediated by proteins that interact with 
PCNA at the replication forks (polδ, polε, Fen1, Lig1, DNMT1, MSH2, CAF-1 to 
name but a few) [12]. PCNA is also implicated in DNA repair pathways that operate 
outside of S phase such as nucleotide and base excision repair [12]. Many proteins 
that interact with PCNA do so via a conserved PCNA-interaction protein (PIP) motif 
[13].  
 
Connecting Cdt1 and PCNA 
 
A recent study using a Xenopus laevis cell-free replication system showed that the S 
phase-dependent ubiquitination and degradation of Cdt1 both required replication and 
took place on the chromatin [14]. In an extension of this work this has now been 
shown to require an interaction between Cdt1 and PCNA mediated by a PIP motif in 
the N terminus of Cdt1 [8]. This PIP motif was necessary and sufficient for Cdt1-
PCNA binding. Mutation of this motif, or PCNA depletion, or prevention of the Cdt1-
PCNA interaction using a competitor peptide, prevented the replication-dependent 
ubiquitination and subsequent degradation of Cdt1. Importantly addition of excess 
Cdt1 with a mutated PIP motif was sufficient to induce re-replication in this system, 
highlighting the importance of this degradation for genome stability. The Cul4-DDB1 
ubiquitin ligase was responsible for this ubiquitination as depletion of DDB1 
prevented Cdt1 degradation. Interestingly, DDB1 and Cdt1 co-immunoprecipitated 
even in non-replicating extracts but the E3 ligase activity of the complex became 
activated upon Cdt1 binding to chromatin-associated PCNA [8]. Hence it seems that 
in Xenopus eggs, replication-dependent degradation of Cdt1 is largely controlled by a 
PCNA and Cul4-DDB1 mediated ubiquitination. This fits with data from C. elegans 
showing that Cul4 removal induces re-replication [7]. 
 
In contrast, in human cells although Cul4-DDB1 ligase has been implicated in the 
degradation of Cdt1 after DNA damage [4, 15] (see below), the control of its 
degradation in S phase has remained mysterious. Cdt1 contains a cyclin E/A 
interaction domain which recruits cyclin-CDK and results in CDK-dependent 
phosphorylation of threonine 29 of Cdt1 [16-18]. This modification allows the 
recruitment of the E3 ubiquitin ligase SCF-Skp2. This might reasonably be expected 
to result in Cdt1 degradation, but abrogation of this pathway is not sufficient to 
completely prevent Cdt1 destruction in human cells [6, 16-18]. Two recent studies 
[10, 11] provide an explanation for this observation that ties in perfectly with the data 
from Xenopus. As well as by the SCF-Skp2 pathway, human Cdt1 was found to be 
degraded by Cul4-DDB1 in a PCNA-dependent manner [10, 11]. Thus, redundancy 
between the SCF-Skp2 and the Cul4-DDB1-dependent ubiquitination pathways 
explains why inhibition of either separately is insufficient to prevent Cdt1 destruction, 
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and indeed, co-inhibition of both these pathways by siRNA is sufficient to stabilise 
Cdt1 in S-phase [10].  
 
Cdt1 degradation after DNA damage 
 
The degradation of Cdt1 in response to DNA damage has been proposed to act as a 
checkpoint preventing continued origin licensing, and thus replication initiation, until 
repair is complete [15]. This is mediated by Cul4-DDB1 [4, 15]. As with the S-phase 
degradation, this ubiquitination and subsequent destruction is now also shown to 
require an interaction between Cdt1 and PCNA, both in human cells and in S. pombe 
[9-11]. PCNA is essential for DNA synthesis during the repair of UV damage and 
becomes associated with chromatin during this process, so the biochemical 
mechanism of these degradation events is likely to be similar.  
 
Concluding remarks 
 
Although these studies are in general complementary there are some discrepancies 
between them that may be the result of species differences or experimental set-ups, 
but which need to be resolved. For example the studies in human cells suggests that 
Cdt1 and PCNA constitutively interact [9-11], at least when Cdt1 is over expressed, a 
conclusion which is not supported by the Xenopus data [8]. Importantly however, the 
Arias and Walter paper demonstrated that only chromatin bound PCNA is capable of 
triggering the Cdt1 destruction [8]. This is essential to ensure that the licensing 
activity is destroyed only at those origins that have fired, and that the degradation of 
Cdt1 is spatially limited within the cell. Verification that the same holds in human 
cells, as well as identification of the mechanism preventing activation of Cdt1 
destruction by soluble PCNA remain crucial aims for the future.   
 
Over expression of Cdt1 is found in some non-small cell lung carcinomas and cancer 
cell lines [19, 20], and it has oncogenic potential [21, 22]. Hence it is likely that in 
some tumour types the balance between origin licensing and firing is perturbed. While 
this may contribute to genomic instability that can be a driving force for tumour 
development, it could also be seen as an “Achilles’ heel” for these cells. The multiple 
redundant methods evolved by cells to ensure licensing control suggests that it is 
crucial for the cell to properly regulate licensing activity. It may be possible to 
develop strategies that target the remaining licensing control mechanisms in these 
Cdt1-dysregulated tumours. While the normal cells of the patient would be resistant to 
such treatment due to their unperturbed control of Cdt1, the tumours would then have 
lost all control of licensing activity, presumably a lethal event. This hypothesis could 
be initially tested in tissue culture systems using siRNA technology and, if successful, 
efforts to identify small molecules that interfere with, for example, Cdc6 activity or 
regulation, would be justified. 
 
Figure legends 
 
Figure 1 – A simplified view of the control of origin licensing and origin firing 
throughout the cell cycle. 
Cells are either in a licensing state, characterised by the association of inactive 
MCM2-7 proteins with the origin recognition complexes (ORC) at origins, or a firing 
state, characterised by active replications forks in which MCM2-7 has moved away 
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from the origin and DNA synthesis can occur. The mutually exclusive nature of these 
states is ultimately regulated by the CDK activities, which control key licensing and 
firing components such as Cdc6 and Cdt1 or Cdc7 and Dbf4, respectively, by a 
variety of mechanisms – see text and Figure 2 for details. 
 
Figure 2 – Multiple mechanisms to prevent origin licensing activity during origin 
firing stages. 
Cdc6 and Cdt1 are two crucial regulators of origin licensing as they enable the 
binding of the helicase MCM2-7 to ORC at origins. In order to prevent re-replication 
licensing activity and origin firing activity must be tightly regulated. This is achieved 
by a variety of mechanisms. Four recent papers have demonstrated that PCNA is 
essential to mediate one of these (the proteasomal degradation of Cdt1) – see text for 
details. 
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Glossary 
 
Replication origin 
A genomic locus at which DNA replication can initiate. In S. cerevisiae replication 
origins have specific sequence requirements but to date the determinants of 
replication origins in higher eukaryotes remains unclear. 
 
Pre-replication complex (Pre-RC)  
The protein-DNA complex that assembles on a replication origin and serves to 
mark the places where replication can commence. 
 
Licensing 
The process of assembling pre-RCs at replication origins and priming them to a 
state competent to fire. 
 
Re-replication 
The result of loss of control of licensing and firing activities that results in some or 
all of the genome being replicated multiple times in the same S phase. 
 
Cyclin dependent kinases (CDKs) 
The various protein kinases that control progression through the cell cycle and 
are activated by association with specific cyclin partners. 
 
Proteasome 
A multi protein proteolysis complex that recognises and degrades poly-
ubiquitinated target proteins. 
 
Ubiquitin ligase 
An enzyme that covalently attaches ubiquitin to substrate proteins, in the cases 
described here resulting in their recognition and degradation by the proteasome. 
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